Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration.

Front Immunol · 2025 · PMC12757277 · PMID 41488668

Europe PMC DOI

hedged sentence

0.1066

closest p · 2.1× alpha

0.1066

boldest claim

The sentences

did not reach statistical significancep=0.1066not close (p > 0.1)

2.391 in controls), although this difference did not reach statistical significance ( Figure 3D ; p=0.1066, unpaired t-test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.